inveox

inveox GmbH, founded in 2017, is a dynamic player in healthcare technology with a mission to revolutionize histopathology through digital automation. By connecting and automating pathology laboratories, inveox enhances the efficiency and safety of cancer diagnostics, minimizing the risk of misdiagnoses and operational irregularities. This innovation promises significant improvements in patient safety.

The company has already gained industry recognition, accruing accolades such as Startup des Jahres 2017 and a mention on the 2018 Forbes list of most promising startups. Additionally, their collaborative involvement with the Roche Diagnostics/Plug&Play Digital Health Accelerator underscores their influential role in the field. Based in Germany, inveox attracts attention with a successful early VC investment round securing €17.00M as of August 2019.

With its rigorous focus on enhancing healthcare delivery, inveox remains a compelling investment opportunity for stakeholders interested in the evolving intersection of healthcare and technology.